LeadIQ logo
Learn more at LeadIQ.com

Insights

AI-driven drug discovery BenevolentAI is a leader in applying advanced AI to drug discovery, increasing success rates and reducing timelines, presenting a sales opportunity for pharmaceutical companies looking to enhance their R&D processes.

Established AI technology The proprietary Benevolent PlatformTM is a validated and established AI drug discovery technology that spans across Target Identification, Chemistry, and Drug Repurposing, offering a proven solution for enterprises seeking cutting-edge tools in biotechnology research.

London - Hub of innovation Being headquartered in London, a global hub for innovation and biotechnology, BenevolentAI has access to a rich pool of talent and resources, making it an attractive partner for companies looking to tap into the UK's thriving tech ecosystem.

Impressive financials With a revenue between $50M - 100M and $90M in funding, BenevolentAI showcases financial stability and growth potential, making it an appealing choice for strategic partnerships or investments within the biotech sector.

Competitive landscape When compared to similar companies like BenchSci, Insilico Medicine, or Schrödinger, BenevolentAI stands out with its AI-focused approach to drug discovery, presenting a differentiation point that can be leveraged in sales pitches to highlight its unique value proposition.

BenevolentAI Tech Stack

BenevolentAI uses 8 technology products and services including Grafana, jsDelivr, NoSQL, and more. Explore BenevolentAI's tech stack below.

  • Grafana
    Analytics
  • jsDelivr
    Content Delivery Network
  • NoSQL
    Database
  • Microsoft
    Miscellaneous
  • Qualys
    Network Security
  • Webflow
    Page Builders
  • Amazon Web Services
    Platform As A Service
  • Node.js
    Programming Languages

Media & News

BenevolentAI's Email Address Formats

BenevolentAI uses at least 2 format(s):
BenevolentAI Email FormatsExamplePercentage
First.Last@benevolent.aiJohn.Doe@benevolent.ai
95%
First.Middle@benevolent.aiJohn.Michael@benevolent.ai
2%
First.Middle.Last@benevolent.aiJohn.Michael.Doe@benevolent.ai
2%
First.MiddleLast@benevolent.aiJohn.MichaelDoe@benevolent.ai
1%
First.Last@benevolent.comJohn.Doe@benevolent.com
75%
First@benevolent.comJohn@benevolent.com
21%
FirstLast@benevolent.comJohnDoe@benevolent.com
4%

Frequently Asked Questions

Where is BenevolentAI's headquarters located?

Minus sign iconPlus sign iconBenevolentAI's main headquarters is located at Maple Street 4-8 London, Greater London W1T 5HD GB. The company has employees across 5 continents, including EuropeNorth AmericaAfrica.

What is BenevolentAI's stock symbol?

Minus sign iconPlus sign iconBenevolentAI is a publicly traded company; the company's stock symbol is BAI.AS.

What is BenevolentAI's official website and social media links?

Minus sign iconPlus sign iconBenevolentAI's official website is benevolent.com and has social profiles on LinkedIn.

How much revenue does BenevolentAI generate?

Minus sign iconPlus sign icon As of January 2025, BenevolentAI's annual revenue reached $75M.

What is BenevolentAI's SIC code NAICS code?

Minus sign iconPlus sign iconBenevolentAI's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BenevolentAI have currently?

Minus sign iconPlus sign iconAs of January 2025, BenevolentAI has approximately 222 employees across 5 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Executive Officer: B. S.Chief People Officer: A. F.Chief Technology Officer: J. M.. Explore BenevolentAI's employee directory with LeadIQ.

What industry does BenevolentAI belong to?

Minus sign iconPlus sign iconBenevolentAI operates in the Biotechnology Research industry.

What technology does BenevolentAI use?

Minus sign iconPlus sign iconBenevolentAI's tech stack includes GrafanajsDelivrNoSQLMicrosoftQualysWebflowAmazon Web ServicesNode.js.

What is BenevolentAI's email format?

Minus sign iconPlus sign iconBenevolentAI's email format typically follows the pattern of . Find more BenevolentAI email formats with LeadIQ.

How much funding has BenevolentAI raised to date?

Minus sign iconPlus sign icon As of January 2025, BenevolentAI has raised $90M in funding. The last funding round occurred on Sep 17, 2019 for $90M.

When was BenevolentAI founded?

Minus sign iconPlus sign iconBenevolentAI was founded in 2013.
BenevolentAI

BenevolentAI

Biotechnology ResearchGreater London, United Kingdom201-500 Employees

BenevolentAI is a pioneer and leader in applying advanced AI to drug discovery and development. 

In a world where drug development failure rate exceeds 90% and thousands of complex diseases lack treatment, our technology can increase the probability of success and reduce timelines. 

Our proprietary Benevolent PlatformTM is one of the industry's most established and validated AI drug discovery technologies. Expertise across Target Identification, Chemistry and Drug Repurposing enables us to deliver across the entire R&D lifecycle. We unite science and technology to serve patients with complex diseases – because it matters.

BenevolentAI is headquartered in London, UK.

Section iconCompany Overview

Headquarters
Maple Street 4-8 London, Greater London W1T 5HD GB
Website
benevolent.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BAI.AS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $90M

    BenevolentAI has raised a total of $90M of funding over 3 rounds. Their latest funding round was raised on Sep 17, 2019 in the amount of $90M.

  • $50M$100M

    BenevolentAI's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $90M

    BenevolentAI has raised a total of $90M of funding over 3 rounds. Their latest funding round was raised on Sep 17, 2019 in the amount of $90M.

  • $50M$100M

    BenevolentAI's revenue is in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    B. S.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. F.
    Chief People Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. G.
    Chief Business Officer (formerly Coo), Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. G.
    Vice President Legal & Ip
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    N. H.
    Lead People Partner
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. B.
    People Partner
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. M.
    Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. B.
    Vp Of Ai
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.